Eosinophilia - 43 Studies Found
| Active, not recruiting |
: Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study : Asthma : 2015-08-31 :
|
| Completed |
: Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients : Asthma : 2015-09-17 :
|
| Completed |
: Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control : Asthma : 2014-10-30 :
|
| Active, not recruiting |
: Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients : Asthma : 2016-01-11 :
|
| Completed |
: A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma : Eosinophils, Asthma : 2017-02-07 : Drug: reslizumab 110-mg |
| Completed |
: Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma : Asthma : 2011-03-09 :
|
| Enrolling by invitation |
: Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma :
: 2015-09-22 :
|
| Completed |
: Study of Mepolizumab Autoinjector in Asthmatics : Asthma : 2017-03-29 : Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
| Active, not recruiting |
: Study of Mepolizumab Safety Syringe in Asthmatics : Asthma : 2017-01-12 : Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
| Active, not recruiting |
: Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children : Asthma : 2015-02-26 : Drug: Mepolizumab Mepolizumab is supplied as 100 mg lyophilised cake in sterile vials for subcutaneous a |